Helmy S - Search Results

1

Efficacy and safety of sofosbuvir plus daclatasvir or ravidasvir in patients with COVID-19: A randomized controlled trial.

Abbass S, Kamal E, Salama M, Salman T, Sabry A, Abdel-Razek W, Helmy S, Abdelgwad A, Sakr N, Elgazzar M, Einar M, Farouk M, Saif M, Shehab I, El-Hosieny E, Mansour M, Mahdi D, Tharwa ES, Salah M, Elrouby O, Waked I. Abbass S, et al. Among authors: helmy s. J Med Virol. 2021 Dec;93(12):6750-6759. doi: 10.1002/jmv.27264. Epub 2021 Aug 24. J Med Virol. 2021. PMID: 34379337 Free PMC article. Clinical Trial.

2

Effectiveness of ravidasvir plus sofosbuvir in interferon-naïve and treated patients with chronic hepatitis C genotype-4.

Esmat G, Elbaz T, El Raziky M, Gomaa A, Abouelkhair M, Gamal El Deen H, Sabry A, Ashour M, Allam N, Abdel-Hamid M, Nada O, Helmy S, Abdel-Maguid H, Colonno R, Brown N, Ruby E, Vig P, Waked I. Esmat G, et al. Among authors: helmy s. J Hepatol. 2017 Sep 19:S0168-8278(17)32286-9. doi: 10.1016/j.jhep.2017.09.006. Online ahead of print. J Hepatol. 2017. PMID: 28935432

3

Efficacy of Sofosbuvir plus Ledipasvir in Egyptian patients with COVID-19 compared to standard treatment: a randomized controlled trial.

Elgohary MA, Hasan EM, Ibrahim AA, Abdelsalam MFA, Abdel-Rahman RZ, Zaki AI, Elaatar MB, Elnagar MT, Emam ME, Hamada MM, Abdel-Hamid TM, Abdel-Hafez AS, Seadawy MG, Fatoh AR, Elsaied MA, Sakr MA, Elkady AO, Shehata MM, Nawar OM, Selem MA, Abd-Aal MS, Lotfy HH, Elnagdy TR, Helmy S, Mubark MA. Elgohary MA, et al. Among authors: helmy s. J Med Life. 2022 Mar;15(3):350-358. doi: 10.25122/jml-2021-0175. J Med Life. 2022. PMID: 35449996 Free PMC article. Clinical Trial.

4

Sofosbuvir-/Daclatasvir-based therapy for chronic HCV and HCV/hepatitis B virus coinfected patients in Egypt.

Nagaty A, Helmy SH, Abd El-Wahab EW. Nagaty A, et al. Trans R Soc Trop Med Hyg. 2020 Feb 7;114(3):200-212. doi: 10.1093/trstmh/trz079. Trans R Soc Trop Med Hyg. 2020. PMID: 31722032

5

Dual Sofosbuvir/Daclatasvir Therapy in Adolescent Patients With Chronic Hepatitis C Infection.

Yakoot M, El-Shabrawi MH, AbdElgawad MM, Mahfouz AA, Helmy S, Abdo AM, El-Khayat HR. Yakoot M, et al. Among authors: helmy s. J Pediatr Gastroenterol Nutr. 2018 Jul;67(1):86-89. doi: 10.1097/MPG.0000000000001968. J Pediatr Gastroenterol Nutr. 2018. PMID: 29570560

6

Response Tailored Protocol Versus the Fixed 12Weeks Course of Dual Sofosbuvir/Daclatasvir Treatment in Egyptian Patients With Chronic Hepatitis C Genotype-4 Infection: A Randomized, Open-label, Non-inferiority Trial.

Yakoot M, Abdo AM, Abdel-Rehim S, Helmy S. Yakoot M, et al. Among authors: helmy s. EBioMedicine. 2017 Jul;21:182-187. doi: 10.1016/j.ebiom.2017.05.011. Epub 2017 May 17. EBioMedicine. 2017. PMID: 28647541 Free PMC article. Clinical Trial.

7

Effects of Dual Sofosbuvir/Daclatasvir Therapy on Weight and Linear Growth in Adolescent Patients with Chronic Hepatitis C Virus Infection.

Yakoot M, El-Shabrawi MH, AbdElgawad MM, Mahfouz AA, Khalil AF, Kamal NM, Helmy S, Abdo AM, Kamal EM, El-Khayat HR. Yakoot M, et al. Among authors: helmy s. Pediatr Infect Dis J. 2019 Jul;38(7):e154-e157. doi: 10.1097/INF.0000000000002222. Pediatr Infect Dis J. 2019. PMID: 31194713

8

The very-rapid and the ultra-rapid virologic response to two treatment options in patients with chronic hepatitis C: an interim report of a prospective randomized comparative effectiveness study.

Yakoot M, Abdo AM, Yousry A, Helmy S. Yakoot M, et al. Among authors: helmy s. Drug Des Devel Ther. 2015 Nov 11;9:6027-33. doi: 10.2147/DDDT.S95499. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26628861 Free PMC article. Clinical Trial.

9

Efficacy and safety of a herbal mixture (Viron® tablets) in the treatment of patients with chronic hepatitis C virus infection: a prospective, randomized, open-label, proof-of-concept study.

Shawkat H, Yakoot M, Shawkat T, Helmy S. Shawkat H, et al. Among authors: helmy s. Drug Des Devel Ther. 2015 Feb 11;9:799-804. doi: 10.2147/DDDT.S77168. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 25709404 Free PMC article. Clinical Trial.

10

Efficacy of a new local limb salvage treatment for limb-threatening diabetic foot wounds - a randomized controlled study.

Yakoot M, Abdelatif M, Helmy S. Yakoot M, et al. Among authors: helmy s. Diabetes Metab Syndr Obes. 2019 Sep 2;12:1659-1665. doi: 10.2147/DMSO.S210680. eCollection 2019. Diabetes Metab Syndr Obes. 2019. PMID: 31564933 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page